Poland· PL-100231080
Ixiaro
A encephalitis, japanische, inaktiviert, ganzes virus product containing szczepionka przeciw japońskiemu zapaleniu mózgu (inaktywowana, adsorbowana), registered in Poland by Valneva Austria GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Encephalitis, japanische, inaktiviert, ganzes virus is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BA02 (encephalitis, japanische, inaktiviert, ganzes virus), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Encephalitis, japanische, inaktiviert, ganzes virus · ATC J07BA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka przeciw japońskiemu zapaleniu mózgu (inaktywowana, adsorbowana)
- Manufacturer
- Valneva Austria GmbH
- Country
- Poland (PL)
- ATC code
- J07BA02
- ATC class
- Encephalitis, japanische, inaktiviert, ganzes Virus
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990796854
- gtin05909990796861
- gtin05901878600628
- gtin09120040710057
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Encephalitis, japanische, inaktiviert, ganzes virus in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomIxiaro vaccine suspension for injection 0.5ml pre-filled syringesValneva UK Ltd
- United StatesIxiaroVetter Pharma Fertigung GmbH & Co. KG
- FranceIXIARO, suspension injectable. Vaccin de l'encéphalite japonaise (inactivé, adsorbé)VALNEVA AUSTRIA (AUTRICHE)
- BelgiumIxiaroValneva Austria
- IcelandIxiaroValneva Austria GmbH
- NetherlandsIxiaro, suspensie voor injectieIntercell Austria AG
- IrelandIxiaro 6 AU Suspension for injectionIntercell Austria AG
- CanadaIXIAROVALNEVA AUSTRIA GMBH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a5b6a8c0-5613-4e00-937d-c9d6a9c24dc9 GET /v1/drugs/a5b6a8c0-5613-4e00-937d-c9d6a9c24dc9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina do wstrzykiwań",
"source": "urpl",
"strength": "-",
"packaging": "05909990796854 ¦ Rp ¦ EU/1/08/501/001 ¦ 59797\n1 amp.-strzyk. 0,5 ml ¦ 1 igła \n05909990796861 ¦ Rp ¦ Skasowane ¦ EU/1/08/501/002 ¦ 59799\n1 amp.-strzyk. 0,5 ml (1 x 10)\n05901878600628 ¦ Rp ¦ EU/1/08/501/002 ¦ Delfarma Sp. z o.o. ¦ 130320\n1 amp.-strzyk. 0,5 ml\n09120040710057 ¦ Rp ¦ EU/1/08/501/002 ¦ 133093\n1 amp.-strzyk. 0,5 ml",
"substance": "Wirus japońskiego zapalenia mózgu, szczep SA14-14-2 (inaktywowany) cakowita zawartość białka: 6 mcg (co odpowiada mocy <= 460 ng ED50); wirus namnożony na komórkach Vero, adsorbowany na glinu wodorotlenku, uwodnionym 0,25 miligramów Al3+",
"common_name": "Szczepionka przeciw japońskiemu zapaleniu mózgu (inaktywowana, adsorbowana)",
"pl_product_id": "100231080",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about encephalitis, japanische, inaktiviert, ganzes virus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.